Journal profile · Peripheral Vascular Disease
Seminars in Thrombosis and Hemostasis
ISSN 0094-6176 · eISSN 1098-9064 · Thieme Medical Publishers · UNITED STATES · Bimonthly · Founded 1974
Seminars in Thrombosis and Hemostasis: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.22; hybrid open access; review 6–12 weeks (community reports); community-reported acceptance: moderate; 118 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Seminars in Thrombosis and Hemostasis is published by Thieme Medical Publishers and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms and Platelet Disorders and Treatments, together about 41.3% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Target Readership: Seminars in Thrombosis and Hemostasis is one of the premiere review journals in the field for all those working in cardiovascular medicine, including cardiologists, neurologists, internists, cardiology researchers, nurse practitioners and general physicians.Journal Purpose and Mission: Seminars in Thrombosis and Hemostasis is a topic-driven publication and serves as a comprehensive forum for important advances in clinical and laboratory diagnosis and therapeutic interventions offering an informed perspective on today's pivotal issues.Types of Articles Published: Seminars in Thrombosis and Hemostasis is a topic driven review journal that also publishes peer-reviewed original research papers. Publication Frequency: The journal publishes 8 issues per year. Subject and Content Scope: The journal publishes invited review articles as well as peer reviewed original research papers on topics including hemophilia A & B, thrombophilia, gene therapy, venous and arterial thrombosis, von Willebrand disease, vascular disorders and thromboembolic diseases. Attention is also given to the latest developments in pharmaceutical drugs along with treatment and current management techniques.
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Editor-in-chief Emmanuel J. FavaloroPublisher website
Editorial board by country: none in mainland China; most named United States 11, Italy 6, Australia 4, Ireland 4, United Kingdom 3 (45 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Venous Thromboembolism Diagnosis and ManagementMedicine15.6%
- Blood Coagulation and Thrombosis MechanismsMedicine13.8%
- Platelet Disorders and TreatmentsMedicine11.8%
- Hemophilia Treatment and ResearchMedicine6.5%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine6.2%
- Heparin-Induced Thrombocytopenia and ThrombosisMedicine5.8%
- Atrial Fibrillation Management and OutcomesMedicine5.3%
- Blood properties and coagulationMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Current ContentsPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.22LetPub ·
- Impact factor (publisher)
- 4.1Publisher website ·
- CiteScore 2026-06
- 8.8LetPub ·
- CiteScore (publisher)
- 1Publisher website ·
- SJR 2026-06
- 1.1LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 92LetPub ·
- h-index
- 138OpenAlex ·
- i10-index
- 2,693OpenAlex ·
- 2-year mean citedness
- 4.81OpenAlex ·
- Self-citation rate
- 19%LetPub ·
- Share of gold OA articles
- 7.59%LetPub ·
Volume
- Articles per year
- 75LetPub ·
Articles by year OpenAlex count · 4,465 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 106 | 26 | 509 |
| 2025 | 118 | 23 | 226 |
| 2024 | 124 | 54 | 940 |
| 2023 | 120 | 52 | 1,292 |
| 2022 | 153 | 58 | 2,103 |
| 2021 | 144 | 58 | 2,403 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Thieme Medical Publishers
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1974
- ISSN
- 0094-6176
- Electronic ISSN
- 1098-9064
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Seminars in Thrombosis and Hemostasis
What CAS zone is Seminars in Thrombosis and Hemostasis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Seminars in Thrombosis and Hemostasis is in Zone 3 of Medicine, and in Zone 3 of the minor category Hematology / Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Seminars in Thrombosis and Hemostasis?
The latest impact factor listed by LetPub is 4.22; CiteScore 8.8, h-index 138.
How long does peer review take at Seminars in Thrombosis and Hemostasis?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Seminars in Thrombosis and Hemostasis based?
Of the 45 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (11), Italy (6) and Australia (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Seminars in Thrombosis and Hemostasis?
According to LetPub and DOAJ records, Seminars in Thrombosis and Hemostasis is indexed in SCIE and Scopus. The journal's website also lists Current Contents; that list has not been checked against each database.
Is Seminars in Thrombosis and Hemostasis open access, and what is the APC?
Seminars in Thrombosis and Hemostasis is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .